ArticlePatient preference and adherence2026

Quantifying the Tolerability of Dopamine Agonist Antiparkinsonian Medication Side Effects: A Best-Worst Scaling Survey.

Kristin Richards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.